Effects of nintedanib in patients with idiopathic pulmonary fibrosis by GAP stage

We conducted a post hoc analysis to assess the potential impact of GAP (gender, age, physiology) stage on the treatment effect of nintedanib in patients with idiopathic pulmonary fibrosis. Outcomes were compared in patients at GAP stage I versus II/III at baseline in the INPULSIS® trials. At baselin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryerson, Christopher J., Kolb, Martin, Richeldi, Luca, Lee, Joyce, Wachtlin, Daniel, Stowasser, Susanne, Poletti, Venerino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487272/
https://www.ncbi.nlm.nih.gov/pubmed/31044139
http://dx.doi.org/10.1183/23120541.00127-2018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487272/
https://www.ncbi.nlm.nih.gov/pubmed/31044139
http://dx.doi.org/10.1183/23120541.00127-2018

Ejemplares similares